Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. junior Avg
|
New words:
AbecmaTM, ACA, accidental, AEs, afamicel, Agriculture, alongside, appellate, avoid, behavior, biochemistry, Brewer, BreyanziTM, calendar, CARVYTKITM, Catalyst, CBER, CCPA, CDRH, chromosomal, Circuit, clarification, commensurate, commodity, compelling, complementary, conflict, consummated, cord, CRL, customary, cybersecurity, cycle, Dear, Dec, deferral, deletion, denied, deny, deprioritizing, detention, disadvantage, domicile, EbvalloTM, Eleventh, email, FDASIA, FDCA, FDORA, fight, fuel, GDPR, GE, geopolitical, GOG, greatly, hemorrhage, hypophosphataemia, ideally, IMM, impermissibly, impracticable, inactive, inappropriate, invasion, IRA, Joanna, KymriaTM, laryngeal, leukopenia, Lifileucel, literature, magnify, mandated, merge, monotherapy, Nineteen, nivolumab, Nov, PDFUA, PDUFA, pendency, pharmacy, pharyngeal, platinum, possession, preclusive, preeminent, programme, promptly, ratably, rationale, real, redundancy, representation, respiratory, retention, revolutionize, runway, Russia, sciatica, settled, shortly, signaled, signaling, sixty, strictly, suite, TecartusTM, theft, thereof, transmit, transparency, Ukraine, umbilical, unanimously, underling, verification, waive, waived, Welfare, wrong, YescartaTM
Removed:
abdominal, AFP, AG, alter, AML, axicabtagene, bile, bladder, build, carcinoma, ciloleucel, clarify, communicating, comparing, conform, died, display, disrupt, disruptive, duct, educational, enrolled, enrolling, expansion, extracellular, fill, footprint, HCC, heart, hematological, integrity, intracellular, investigator, joint, Kymriah, medigene, MM, moiety, multitude, muscle, myelodysplastic, myxoid, narrower, occupied, pain, pause, phage, physical, planning, precautionary, reactivity, repeated, represented, round, safer, stable, strength, strong, Subtopic, sustained, Takeda, tisagenlecleucel, TITIN, uninterrupted, unwinding, upgrade, utility, vomiting, vulnerable, WR, Yescarta
Filing tables
Filing exhibits
Associated ADAP transcripts
ADAP similar filings
Filing view
External links
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the registration statements No. 333-233557 on Form S-3 and Nos. 333-233558 and 333-203929 on Form S-8 of Adaptimmune Therapeutics plc of our reports dated March 6, 2023, with respect to the consolidated financial statements of Adaptimmune Therapeutics plc and the effectiveness of internal control over financial reporting.
/s/ KPMG LLP
Reading, United Kingdom
March 6, 2023